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Background: Infective endocarditis is the most serious manifestation of cardiac device infection and
metastatic seeding of distant sites has been reported. However, the association between device-related
endocarditis and spinal abscess has not been fully described.
Methods: We reviewed hospital records at three high-volume cardiovascular referral centers from
January 2005 to October 2010. Device-related endocarditis was confirmed in all cases with positive blood
cultures and transesophageal echocardiogram revealing lead and/or valvular vegetations. Six patients
with spinal abscesses in association with device-related endocarditis were identified.
Results: A total of 384 patients met the clinical criteria for device-related endocarditis. Among these,
infection was complicated by spinal abscess formation in six (1.5%) cases. The mean age of patients was
69.3 ± 11.8 years (47–82 years). The predominant clinical manifestations in these six patients included
a recent history of fever (six), malaise (four), and neurological or meningeal signs (five). Spinal abscesses
were diagnosed by magnetic resonance imaging in two and computed tomography scans in four of the
cases. The causative pathogens were methicillin-resistant Staphylococcus aureus (three), methicillin-
sensitive S. aureus (one), coagulase-negative Staphylococci (two), and Enterococcus fecalis (one). All
patients underwent complete device removal with no procedure-related complications. Two patients
died in the hospital, two were discharged with permanent neurological deficits, and the remaining two
recovered with no permanent neurologic sequelae.
Conclusion: Device-related endocarditis must be considered in patients who present with a spinal
abscess and bacteremia. Early recognition of this scenario is imperative in order to avoid permanent
neurological sequelae and patient mortality. Early imaging, appropriate parenteral antimicrobial therapy,
and expedited removal of all cardiac hardware are pivotal for optimal management. (PACE 2012;
35:269–274)
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Introduction
Device-related endocarditis has been recog-
nized since the early 1970s, yet it remains a
devastating condition that may be associated
with multiple complications including the de-
velopment of septic emboli.1–3 The relationship
between bacteremia and distant foci of infec-
tion has been highlighted.1,4 However, despite
knowledge of the prevalence and complications
associated with device-related endocarditis, the
association with spinal abscess has not been fully
explored.
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Implantation of cardiovascular implantable
electronic devices (CIED), both pacemakers (PMs)
and implantable cardioverter-defibrillators (ICDs),
is increasing. However, benefits of these devices
may be eclipsed by increasing rate of device
infections.5,6 A review of the National Hospital
Discharge Survey from 1996 to 2003 demonstrated
that there was a 3.1-fold increase in the number of
hospitalizations attributed to CIED infections.1,7
Another analysis revealed a 124% increase in
CIED infections among Medicare beneficiaries
from 1990 to 1999, with the incidence of device-
related endocarditis increasing from 0.26 to 0.39
cases of 1,000 beneficiaries.1,8 More recent data
indicate that the incidence of device-related
endocarditis is approximately 1.14 of 1,000
device-years.1 As the rate of CIED implantation
and associated infectious complications increases,
healthcare practitioners should expect more fre-
quent and varied clinical presentations.
Device-related endocarditis is associated with
a high cost, including both resource utilization and
mortality. The mean hospital length of stay (LOS)
C©2011, The Authors. Journal compilation C©2012 Wiley Periodicals, Inc.
PACE, Vol. 35 March 2012 269
RODRIGUEZ, ET AL.
for patients who experience device infections,
including device-related endocarditis, ranges from
14.4 to 19.6 days and the total cost associated
with these hospitalizations ranges from $33,149
to $55,003.9 The mortality rate associated with
cardiac device-related endocarditis ranges from
31% to 66% if the implantable device is not
extracted, and 13%–21% in the setting of com-
plete device removal combinedwith antimicrobial
therapy.10,11
The rising incidence of CIED infections em-
phasizes the importance of accurate and prompt
identification of the varied clinical presentations
associated with this complication. We summarize
our experience with patients presenting with
CIED-related infective endocarditis complicated
by spinal abscess formation. The prompt recog-
nition and expedited management of this clinical
scenario is pivotal in avoiding serious sequelae,
such as paraplegia and patient mortality.
Methods and Results
We reviewed hospital records dating from
January 2005 to October 2010 at three high-
volume cardiovascular referral centers. Patients
with concomitant spinal abscess were identified
in a cohort of 384 patients with device-related
endocarditis. The diagnosis of device-related
endocarditis was based on the modified Duke
criteria.12 These criteria have also been validated
in cases of device-related endocarditis in a recent
publication from Mayo Clinic.13 Briefly, device-
related endocarditis was present if there was
persistent bloodstream infection, documented by
positive blood cultures, and a lead vegetation doc-
umented by echocardiography. A spinal abscess
was documentedwith noninvasive imaging (either
computed tomography (CT) ormagnetic resonance
imaging [MRI]) in all cases.
Six patients with device-related endocarditis
and spinal abscess were identified. A trans-
esophageal echocardiogram (TEE) revealed the
presence of lead vegetations in all patients and
all six had positive blood cultures. The patient
demographics and clinical course are summarized
in Table I. The mean age of the group was 69 ±
12 years (range, 47–82 years). The predominant
clinical presentation of these patients (three male,
three female) included a recent history of fever
(six), malaise (four), and neurologic or meningeal
signs (five). Only one patient had a recent
local procedure to the spine, receiving epidural
injections for chronic lower back pain. The
pathogens isolated were Staphylococcus aureus
in four patients, coagulase-negative staphylococci
in one patient, and both Enterococcus fecalis and
coagulase-negative staphylococci in one patient.
Methicillin resistance was present in three of the
four patients with S. aureus infection. A spinal
abscess was confirmed by MRI in two cases and
CT scan in the remaining four patients. Complete
device extraction was performed in all patients
and none had procedure-related complications.
All patients were treated with prolonged par-
enteral antibiotics. Surgical decompression of the
spinal abscess was performed in three of the
six cases. Partial neurologic recovery occurred
in only one patient, while one patient had
continued paraplegia and the third one expired
5 months later due to continued downhill course,
including recurrent fever. Two patients did not
undergo surgical decompression since they had
local pain but no neurologic findings. These
patients’ symptoms improved with removal of
their CIED hardware and a prolonged course of
intravenous antibiotic therapy. The sixth patient
with acute paraplegia did not undergo surgical
decompression at the request of the family. This
patient died during the hospitalization.
Illustrative Cases
Case One
A 65-year-old female had a past medical his-
tory (PMH) significant for coronary artery disease
(CAD) status post percutaneous coronary inter-
vention (PCI), ischemic cardiomyopathy (ejection
fraction 30%), a cerebrovascular accident (CVA),
and previous oral surgery for oral carcinoma. She
had undergone ICD placement in April 2008.
The patient presented to an outside hospital in
May 2010 with altered mental status, slurred
speech, unsteady gait, fever, chills, and malaise.
Blood cultures were positive for methicillin-
sensitive Staphylococcus aureus (MSSA). TEE
demonstrated multiple vegetations attached to the
ICD leads. The patient was started on Vancomycin
and transferred to our institution for management
of the CIED infection. The patient developed
worsening back pain over the next 2 days that
included the entire lower lumbar zone. The patient
was switched to Cefazolin and Gentamicin. The
infected ICD and leads were extracted using a laser
sheath. After device removal, a spinal MRI was
performed to evaluate the back pain and revealed
a spine abscess in the lumbar region (Figs. 1
and 2). Neurosurgery evaluated the patient and
recommended conservative management due to
the absence of neurological deficits. The patient’s
lower back pain gradually improved and she was
discharged home approximately 1 month later
without any permanent neurological deficits. The
patient was well at 1-month, 2-month, and 1-year
follow-up.
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Table I.
Clinical Characteristics of the Six Patients with a Spinal Abscess Associated with Device-Related Endocarditis
Case Age Neurological
No. (Years) Device Pathogen Risk Factor(s) Signs or Deficit Management Outcome
One 65 ICD MSSA Heart failure, history
of cancer, ICD, S.
aureus
Lower back pain Complete device
extraction
IV antibiotics
Surgical
decompression of
abscess not
performed due to
absence of
neurological
deficits
No neurological deficits
Well at 1-year follow-up
Two 47 Dual-
chamber
PM
MRSA Diabetes mellitus,
S. aureus, oral
anticoagulation
Acute paraparesis Complete device
extraction
IV antibiotics
Surgical
decompression of
abscess
performed
Paraplegia
Patient doing well
otherwise.
Three 74 ICD CoNS Heart failure, ICD Lower back pain Complete device
extraction
IV antibiotics
Surgical
decompression of
abscess not
performed
No neurological deficits
Well at 2-month
follow-up.
Awaiting reimplantation
pending resolution of
spinal abscess
Four 82 Dual-
chamber
PM
MRSA Diabetes mellitus,
S. aureus
Bilateral leg
weakness
Complete device
extraction
IV antibiotics
Family declined
surgical
decompression of
spinal abscess
Patient died during
hospitalization
Five 81 CRT-PM MRSA Diabetes mellitus,
heart failure, S.
aureus
Meningeal signs
initially, the
patient proceeded
to develop
paraplegia
Complete device
extraction
IV antibiotics
Surgical
decompression of
abscess
performed
Patient died 5 months
after hospital
discharge while at a
skilled nursing facility
Six 67 ICD Enterococcus
fecalis and
CoNS
Heart failure,
diabetes mellitus,
ICD
Paraplegia Complete device
extraction
IV antibiotics
Surgical
decompression of
abscess
performed
Experienced partial
recovery from
neurological deficits
Patient was well at
follow-up.
PM = pacemaker; ICD = implantable cardioverter defibrillator; CRT-PM = cardiac resynchronization therapy pacemaker; MSSA = methicillin-sensitive
Staphylococcus aureus; MRSA = methicillin-resistant Staphylococcus aureus; CoNS = coagulase-negative staphylococcus; IV = intravenous.
Case Two
A 47-year-old female with PMH significant
for diabetes mellitus (DM), chronic renal insuf-
ficiency, previous CVA, and sick sinus syndrome
(SSS) requiring the placement of a dual-chamber
PM in 2003, presented to an outside hospital
in February 2005 with complaints of fever and
bilateral legweakness. Initial workup leukocytosis
(white blood cell count 18.3 ×109/mL) and blood
cultures were positive for methicillin-resistant S.
aureus (MRSA). The patient had acute kidney
injury with a creatinine level of 3.4 mg/dL
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Figure 1. MRI from case one. Sagittal view of the spine. The arrow demonstrates a spinal abscess
in the lumbar region.
(elevated from her baseline of 1.2–1.5). Her
condition quickly deteriorated and she developed
acute paraparesis. ACTmyelogramwas performed
and demonstrated a complete block at T 7–8
thoracic spine and a right para-spinal mass.
She was transferred to our facility the next day
for the management of this epidural abscess.
The patient had surgical decompression of this
abscess 1week after admission. Due to persistently
positive blood cultures for MRSA, a TEE was
performed and showed a 1 × 0.7-cm mobile
mass on the right ventricle (RV) lead and an
ejection fraction of 60%. Six days later, the patient
underwent complete device removal and the leads
were pulled using only manual traction. The
patient received a 6-week course of antibiotic
consisting of 42 days of parenteral Vancomycin
and oral Rifampin, and first 14 days of intravenous
Gentamicin. The patient was discharged to a
local rehabilitation facility. She had a follow-up
visit 5 months after her initial presentation, and
was doing well. Her primary care physician kept
her on chronic oral Bactrim therapy for chronic
suppression.
Discussion
There has been an unprecedented increase in
the rate of CIED implantation over the past two
decades. Unfortunately, this was accompanied by
an unanticipated rise in the rate of CIED infection,
both local pocket and systemic infection, as
well.1,5,7,14 Consequently, it is exceedingly impor-
tant that clinicians recognize the varied clinical
manifestations associated with CIED infection.
We present the first case series linking CIED-
related endocarditis with the presence of a spinal
abscess.
Several risk factors have been associated with
the development of CIED infections and device-
related endocarditis.15–17 Clinical risk factors
include immunosuppression, the use of oral
anticoagulation, and medical comorbidities, such
as advanced heart failure, DM, and history of
cancer. There are also device-related factors, such
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Figure 2. MRI from case one. Cross-sectional view of the spine. The arrow demonstrates a spinal
abscess in the lumbar region.
as recent device revision or replacement, the type
of CIED (ICD infection risk > pacemaker infection
risk), and operator inexperience. Moreover, the
microbiology of the organism responsible for
bloodstream infection, particularly S. aureus, also
influences the risk for CIED-related endocarditis
and metastatic complications. All of our patients
had several of these known risk factors,1 including
serious comorbid conditions, such as diabetes,
heart failure, and cancer. Half of our patients
had ICDs, whereas the remainder had either
dual-chamber PMs or a cardiac resynchronization
therapy pacemaker (CRT-PM) device.
Gram-positive organisms are frequently asso-
ciated with CIED infections and device-related
endocarditis. Most of these infections are caused
by the Staphylococcus species, followed by
Enterococci and Streptococci.1,5,9,14–16 All of our
patients with spinal abscesses had blood stream
infection with gram-positive cocci. It is debatable
whether the spinal abscess was the initial source
of bloodstream infection or represented metastatic
seeding from the cardiac source. Only one of our
six patients had a local spine procedure, that is,
epidural injections that may have been the portal
of entry for local infection. The initial source of
bacteremia in the other cases is unclear. However,
discerning the precise source of bacteremia in
these complicated cases may be a moot point, as
it does not influence the management decisions.
Two of the three patients with bacteremia and
spinal abscesses with MRSA in our series died.
Mortality in these cases highlights the importance
of including device-related endocarditis in the
differential diagnosis of patients who present with
bacteremia with gram-positive cocci, particularly
S. aureus, and have an implanted cardiac device.
It is not surprising that S. aureus is
the pathogen most commonly associated with
metastatic infectious complications following
device-related endocarditis.4 It is estimated that
up to 34% of the patients with device-related en-
docarditis will develop infected metastatic foci.18
The most frequently reported site of hematoge-
nous seeding include septic pulmonary emboli,
septic arthritis, osteomyelitis, and spondylitis.4
Metastatic foci may recur if they are overlooked
at initial presentation and unless all infected
hardware is removed.
Although fever (86%–95%) and chills (76%)
are reported by most patients diagnosed with
CIED-related endocarditis,1,4 the clinical presen-
tation can bemore indolent or subtle, especially in
patientswho have received previous antimicrobial
therapy.1,4 In these cases, clinical symptoms may
not suggest underlying CIED-related endocarditis.
It should be noted that the majority of the
patients with CIED-related endocarditis have no
inflammatory changes at the CIED pocket site,19
as seen in our case series. Therefore, arriving
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at the correct diagnosis may be a challenging
process. Thus, presence of a nonspecific ill-
ness, bacteremia, or abscess in patients with
cardiac devices should raise the suspicion for
an underlying CIED infection and device-related
endocarditis. For these reasons, American Heart
Association guidelines recommended that all
patients with CIED and positive blood cultures
should undergo TEE as part of their diagnostic
evaluation.1
Signs and symptoms related to spine involve-
ment can also be nonspecific. In our series, four
of the six patients initially presented with neuro-
logical deficits or meningeal signs in addition to
fever and chills. However, others simply presented
with low back pain, a common complaint in
elderly population with degenerative joint dis-
ease. Therefore, we strongly recommend that a
new or worsening back pain in CIED recipients
with bacteremia should be taken seriously and
investigated further by CT or MRI imaging. In
some of our cases, we could not conclude with
certainty whether the spinal abscess or the CIED
was the initial focus of the infection. However,
regardless of the etiology, prompt administration
of parenteral antimicrobial therapy and removal
of all CIED hardware is necessary for optimal
management.1,4,10
Conclusion
Device-related endocarditis should be ex-
cluded in all patients with CIED who present with
a spinal abscess. The early recognition and prompt
intervention is imperative in order to avoid
permanent neurological sequelae and patient
mortality. Imaging with CT or MRI, prolonged
parenteral antimicrobial therapy guided by in
vitro susceptibility testing, and complete removal
of all CIED hardware are the key management
interventions to achieve cure.
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